Literature DB >> 28425170

Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database.

Aliasghar A Kiadaliri1, David T Felson2, Tuhina Neogi2, Martin Englund3.   

Abstract

OBJECTIVE: To examine trends in rheumatoid arthritis (RA) as an underlying cause of death (UCD) in 31 countries across the world from 1987 to 2011.
METHODS: Data on mortality and population were collected from the World Health Organization mortality database and from the United Nations Population Prospects database. Age-standardized mortality rates (ASMRs) were calculated by means of direct standardization. We applied joinpoint regression analysis to identify trends. Between-country disparities were examined using between-country variance and the Gini coefficient. Due to low numbers of deaths, we smoothed the ASMRs using a 3-year moving average. Changes in the number of RA deaths between 1987 and 2011 were decomposed using 2 counterfactual scenarios.
RESULTS: The absolute number of deaths with RA registered as the UCD decreased from 9,281 (0.12% of all-cause deaths) in 1987 to 8,428 (0.09% of all-cause deaths) in 2011. The mean ASMR decreased from 7.1 million person-years in 1987-1989 to 3.7 million person-years in 2009-2011 (48.2% reduction). A reduction of ≥25% in the ASMR occurred in 21 countries, while a corresponding increase was observed in 3 countries. There was a persistent reduction in RA mortality, and on average, the ASMR declined by 3.0% per year. The absolute and relative between-country disparities decreased during the study period.
CONCLUSION: The rates of mortality attributable to RA have declined globally. However, we observed substantial between-country disparities in RA mortality, although these disparities decreased over time. Population aging combined with a decline in RA mortality may lead to an increase in the economic burden of disease that should be taken into consideration in policy-making.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 28425170     DOI: 10.1002/art.40091

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  14 in total

1.  Rheumatoid arthritis: The benefits of early treatment after decades.

Authors:  Angela Zink; Katinka Albrecht
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

2.  Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.

Authors:  Aliasghar A Kiadaliri; Martin Englund
Journal:  Clin Rheumatol       Date:  2018-01-22       Impact factor: 2.980

3.  In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis.

Authors:  Houda Abir Benabdoun; Merve Kulbay; Elsa-Patricia Rondon; Francis Vallières; Qin Shi; Julio Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2019-03-12       Impact factor: 5.156

4.  Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.

Authors:  Tsutomu Takeuchi; Yoshiya Tanaka; Sakae Tanaka; Atsushi Kawakami; Manabu Iwasaki; Kou Katayama; Mitsuhiro Rokuda; Hiroyuki Izutsu; Satoshi Ushijima; Yuichiro Kaneko; Teruaki Shiomi; Emi Yamada; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2019-07-26       Impact factor: 19.103

5.  Age-Related Changes in Instrumental and Basic Activities of Daily Living Impairment in Older Adults with Very Mild Alzheimer's Disease.

Authors:  Takayuki Tabira; Maki Hotta; Miki Murata; Kazuhiro Yoshiura; Gwanghee Han; Tomohisa Ishikawa; Asuka Koyama; Noriyuki Ogawa; Michio Maruta; Yuriko Ikeda; Takaaki Mori; Taku Yoshida; Mamoru Hashimoto; Manabu Ikeda
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2020-03-24

6.  Association of childhood physical and sexual abuse with arthritis in adulthood: Findings from a population-based study.

Authors:  Philip Baiden; Lisa S Panisch; Henry K Onyeaka; Catherine A LaBrenz; Yeonwoo Kim
Journal:  Prev Med Rep       Date:  2021-06-24

7.  Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model.

Authors:  Yue Teng; Zhanhai Yin; Jing Li; Kun Li; Xu Li; Yan Zhang
Journal:  Oncotarget       Date:  2017-08-03

8.  Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.

Authors:  Tina Marie Kringelbach; Bente Glintborg; Estrid V Hogdall; Julia Sidenius Johansen; Merete Lund Hetland
Journal:  BMJ Open       Date:  2018-02-01       Impact factor: 2.692

9.  Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register.

Authors:  James M Gwinnutt; Deborah P M Symmons; Alexander J MacGregor; Jacqueline R Chipping; Tarnya Marshall; Mark Lunt; Suzanne M M Verstappen
Journal:  Ann Rheum Dis       Date:  2018-02-23       Impact factor: 19.103

10.  Comparative Studies of Different Extracts from Eucommia ulmoides Oliv. against Rheumatoid Arthritis in CIA Rats.

Authors:  Jian-Ying Wang; Xiao-Jun Chen; Lei Zhang; Ying-Yi Pan; Zu-Xi Gu; Shi-Min He; Zhe-Ping Song; Ying Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.